Micron Products, Inc. Appoints Michael Collette as Vice President of Quality
03 March 2015 - 5:30AM
Micron Products, Inc. (Micron), a wholly-owned subsidiary of
Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced
today it has appointed medical device industry professional Michael
Collette as the Company's Vice President of Quality, effective
February 16, 2015. Mr. Collette brings more than 25 years of
extensive quality and regulatory experience to Micron, including a
long career in medical device manufacturing. He has led
quality systems for leading medical device manufacturers, including
NxStage Medical, Cynosure, Vaupell Northeast Molding and Tooling,
and Smiths Medical.
Mr. Collette was most recently an Executive Quality Management
System Consultant for several major medical device companies,
including Micron Products. Prior to consulting, Mike was the
Vice President of Quality for NxStage Medical, where he was
responsible for all Quality Engineering, Post Market Surveillance,
and Supplier Quality activities. He also oversaw strategic
second-sourcing of key manufacturing capabilities, both
domestically and internationally.
"Mike's wealth of experience is an ideal fit for the direction
in which we are taking Micron," said Salvatore Emma, Jr., President
and CEO. "Micron is building its reputation as a world-class
medical device contract manufacturer through innovative products
and services by providing the highest quality and value for its OEM
customers. Mike's leadership and experience will be integral
to our strategy as we add new capabilities, attract new customers
and offer the best quality and value to the medical device
industry."
Mr. Collette stated, "I am excited to become a member of the
Micron Products team and to contribute to the growth of Micron as a
world-class medical device company. The Company is on the
right path to succeed in the ever-changing and increasing complex
medical device world. It is truly an honor to be part of the
Micron family."
About Arrhythmia Research Technology, Inc.
Arrhythmia Research Technology, Inc., through its wholly-owned
subsidiary, Micron Products, Inc., is a diversified contract
manufacturing organization that produces highly-engineered,
innovative medical device technologies requiring precision
machining and injection molding. Micron also manufactures
components, devices and equipment for military, law enforcement,
industrial and automotive applications. The Company is also a
market leader in the production and sale of silver/silver chloride
coated and conductive resin sensors used as consumable component
parts in the manufacture of integrated disposable
electrophysiological sensors. The Company's strategy for
growth is to build a best-in-class quality organization and
capitalize on its engineering design expertise and reliable,
proprietary manufacturing processes to further penetrate its
position in the medical device contract manufacturing
market.
The Company routinely posts news and other important information
on its websites: http://www.arthrt.com and
http://www.micronproducts.com.
Safe Harbor Statement
Forward-looking statements made herein are based on current
expectations of Arrhythmia Research Technology, Inc. ("our" or the
"Company") that involve a number of risks and uncertainties and
should not be considered as guarantees of future performance. The
factors that could cause actual results to differ materially
include our ability to forecast future prospects, to retain
customers who represent significant proportions of revenue; our
ability to maintain our pricing model and/or decrease our cost of
sales; our ability to increase sales of higher margin products and
services; our ability to manage our level of debt and provisions in
the debt agreements which could limit our ability to react to
changes in the economy or our industry; failure to comply with
financial and other covenants in our credit facility; volatility in
commodity and energy prices and our ability to offset higher costs
with price increases; continued availability of supplies or
materials used in manufacturing at competitive prices; variability
of customer delivery requirements; variations in the mix of
products sold; a stable interest rate market and/or a stable
currency rate environment in the world, and specifically the
countries where we are doing business; amount and timing of
investments in capital equipment, sales and marketing, engineering
and information technology resources and our ability to offset
higher costs with price increases. More information about factors
that potentially could affect the Company's financial results is
included in the Company's filings with the Securities and Exchange
Commission.
CONTACT: For more information on Micron Products, Inc.
or Arrhythmia Research Technology, Inc. contact:
Investor and Media Contact:
Deborah K. Pawlowski
Kei Advisors LLC
716.843.3908
dpawlowski@keiadvisors.com
Company Contact:
Derek T. Welch
Chief Financial Officer
978.345.5000
HireRight (NYSE:HRT)
Historical Stock Chart
From Mar 2024 to Apr 2024
HireRight (NYSE:HRT)
Historical Stock Chart
From Apr 2023 to Apr 2024